When a GB 9706.1 CoA Is Not IEC 60601-1 Edition 3.2

When an international medical-device distributor, OEM buyer, or private-label importer reviews a Chinese supplier's qualification packet for active medical electrical (ME) equipment—such as a portable Medical Vacuum NPWT Pump or an automated aesthetic microinjection device—the technical dossier inevitably contains an electrical-safety Certificate of Analysis (CoA) or an inspection type-test summary. In Chinese manufacturing facilities, that document almost universally cites a standard from the GB 9706 series.

A pervasive and commercially hazardous assumption across global procurement teams, frequently reinforced by AI-generated search summaries and factory export sales desks, is that 'GB 9706.1 is identical to IEC 60601-1, so any Chinese electrical safety CoA proves compliance with international 60601 requirements.' In real-world regulatory submissions, this assumption collapses immediately. Treating a Chinese national standard report as a plug-and-play substitute for an IEC 60601-1 tender requirement or an FDA 510(k) Declaration of Conformity triggers immediate deficiency notices, customs holds, and expensive re-testing cycles.

On 16 September 2026, international supply chains operate in an altered regulatory landscape. China's three-year transition window under NMPA Announcement No. 14 of 2023 for updating legacy Class II and Class III active devices to GB 9706.1-2020 officially expired on 1 May 2026—exactly 138 days ago ³. For a new US 510(k) electrical-safety Declaration of Conformity, the current Complete recognition is Recognition Number 19-49 (IEC 60601-1 Edition 3.2) together with US national differences under Rec 19-46; that is a consensus-standard path, not the only lawful method of showing electrical safety ⁵⁶. This guide dismantles the legal identity of Chinese electrical-safety standards, tracks the edition lineage from 1988 to 2026, maps the collateral EMC and home-use boundaries, and provides an actionable incoming audit checklist for procurement teams. The same incoming-identity method was used for Chinese EO CoAs versus ISO 11135 cycle files; this page is the electrical-safety overlay, not a second sterilization article.

Does a GB 9706.1-2007 CoA prove IEC 60601-1 Edition 3.2, or only the abolished 1988 standard?

When reviewing incoming lots or supplier pre-qualification files for Chinese medical electrical equipment, buyers frequently encounter CoAs that prominently display compliance with GB 9706.1-2007. To understand what this certificate legally establishes, examine the official national standard catalog card maintained by China's State Administration for Market Regulation (SAMR) and the National Public Service Platform for Standards Information ².

SAMR's catalog record documents that GB 9706.1-2007 was issued on 2 July 2007, took effect on 1 July 2008, and holds the legal status of 废止 (Abolished) as of 1 May 2023 ². Crucially, its international standard adoption relationship (采标情况) is classified as 等同采用 (Identical Adoption / IDT) of IEC 60601-1:1988—the long-obsolete Second Edition of the International Electrotechnical Commission's general safety standard.

This reveals the first critical audit trap: IEC 60601-1:1988 evaluated electrical safety primarily through prescriptive constructional rules (insulation, dielectric withstand, creepage and clearance). The Third Edition family later added essential-performance evaluation that the 1988 text did not carry. When an overseas importer accepts a CoA citing GB 9706.1-2007 in September 2026, the factory is presenting evidence grounded in a GB that SAMR records as identical to that 1988 edition—and that GB has been abolished.

• What a GB 9706.1-2007 CoA proves: The device hardware satisfied Chinese domestic safety specifications that were mandatory between 2008 and April 2023, verifying basic physical safety principles derived from IEC 60601-1:1988 Second Edition.
• What a GB 9706.1-2007 CoA does not prove: It does not prove compliance with IEC 60601-1 Third Edition (2005), Edition 3.1 (2012), or Edition 3.2 (2020); it does not evaluate essential performance; it does not satisfy FDA Recognition Number 19-49; and it does not satisfy the European Union MDR harmonised standard EN 60601-1:2006/A13:2024.

A CoA citing GB 9706.1-2007 is not proof that the physical equipment is immediately hazardous, but it is definitive proof that the quality documentation is out of date. In a US 510(k) or European MDR technical-file review, a 2007 GB report does not close the current consensus-standard cell; reviewers will treat the identity mismatch as unresolved until the named edition matches the destination overlay.

What did 1 May 2023 change when GB 9706.1-2020 replaced both 2007 and GB 9706.15-2008, and why is MOD 2012 not Rec 19-49?

On 9 April 2020, SAMR and the Standardization Administration of China (SAC) issued GB 9706.1-2020 (Medical electrical equipment — Part 1: General requirements for basic safety and essential performance) with a mandatory implementation date of 1 May 2023 ¹. As of 16 September 2026, GB 9706.1-2020 is the active, governing national standard across the People's Republic of China, holding the status of 现行 (In Force).

The implementation of GB 9706.1-2020 executed two fundamental structural shifts in China's medical electrical regulatory regime: first, it consolidated basic safety and system safety into a single standard, completely replacing (全部代替) both GB 9706.1-2007 and the former medical electrical systems standard GB 9706.15-2008 ¹. Second, its standard adoption status transitioned from identical adoption to 修改采用 (Modified Adoption / MOD) of IEC 60601-1:2012 (Edition 3.1) ¹¹⁴.

This transition brought China's domestic safety regime into the Third Edition philosophy: mandatory evaluation of essential performance, rigorous risk management under ISO 14971 integrated directly into test clauses, software programmable electrical medical systems (PEMS) validation, and mechanical hazard testing. However, procurement leads must recognize the two technical chasms that prevent GB 9706.1-2020 from serving as an automatic proxy for US or European clearance:

• Chasm 1: The Edition Gap (Edition 3.1 vs. Edition 3.2): SAMR records GB 9706.1-2020 as modifying IEC 60601-1:2012, which represents IEC Edition 3.1 (consolidating IEC 60601-1:2005 with Amendment 1:2012) ¹⁴. Conversely, US FDA Recognition Number 19-49 designates IEC 60601-1 Edition 3.2 2020-08 CONSOLIDATED VERSION as Complete ⁵¹⁵. Edition 3.2 is the 2005 base text plus Amendment 1:2012 plus Amendment 2:2020. The public catalog does not reprint Amendment 2's clause-level changes; do not treat a GB 9706.1-2020 report as if it already included Amd 2.
• Chasm 2: The National Differences Gap (MOD vs. US Rec 19-46): SAMR's classification of modified adoption (修改采用) means China incorporated domestic technical deviations. The public SAMR card does not print that difference table, so this page does not invent plug, mains, or climatic clauses from the paywalled GB. In the United States, Rec 19-49 does not stand alone: it is recognized with relevant US national differences applied through FDA Rec 19-46 (ANSI/AAMI ES60601-1:2005/(R)2012 including AMD2:2021) ⁵⁶. A China MOD file is therefore a different overlay from Rec 19-46, not a stamp of the US differences.

Because of these structural gaps, an OEM or distributor presenting a Chinese GB 9706.1-2020 test report as if it were Rec 19-49 should expect a request for an edition-and-differences gap analysis covering Amendment 2:2020 and Rec 19-46, typically supported by an accredited laboratory report. FDA consensus-standard recognition is a least-burdensome Declaration of Conformity path; it is not a unique legal mandate that every 510(k) must use.

The Medical Electrical Equipment Safety & Regulatory Identity Matrix

To assist international distributors, hospital clinical engineers, and quality assurance auditors in rapidly categorizing incoming active medical device documentation, Table 1 details the exact legal status, adoption lineage, authorized market scope, and regulatory limits across governing Chinese, international, US, and European standards as of 16 September 2026.

If a CoA says IEC 60601-1 with no edition, which file is missing?

A recurring documentation failure identified during incoming supplier audits is the bare standard string. A supplier issues a lot release certificate or compliance declaration that simply states: 'Testing Standard: IEC 60601-1 — Conforms.' No edition number, no amendment identifier, and no publication year is listed.

In modern medical device regulatory practice, an undated reference to IEC 60601-1 is legally meaningless. IEC 60601-1 spans multiple incompatible philosophies: Second Edition (1988), Third Edition (2005), Edition 3.1 (2012), and Edition 3.2 (2020) ¹⁴¹⁵. When an incoming CoA omits the edition, the importer or notified body auditor cannot determine whether the equipment was evaluated against 1988 constructional rules or 2020 essential performance criteria.

When a bare 'IEC 60601-1' string appears on an incoming certificate, quality assurance teams should send the file back and request the underlying accredited type-test report. Where the factory holds an IECEE CB Scheme file, the CB Test Certificate and Test Report are the usual way to recover the missing edition, national-difference annex, and essential-performance definition:

• The Exact Standard Base: Identifies whether the laboratory tested against IEC 60601-1:2005, IEC 60601-1:2005+A1:2012 (Edition 3.1), or IEC 60601-1:2005+A1:2012+A2:2020 (Edition 3.2).
• The National Differences Annex: Reveals whether national differences were evaluated. A standard international CB report contains no US national differences unless the manufacturer explicitly contracted the laboratory to test the ANSI/AAMI ES60601-1 deviations.
• The Essential Performance Definition: Confirms whether the manufacturer formally defined essential performance operating limits in their risk management file (e.g., vacuum pressure tolerances in an NPWT pump or dosing accuracy in a microinjector) and verified that safety controls operated during fault conditions.
• Component Criticality Table: Verifies whether safety-critical components (power supply modules, optocouplers, isolation transformers, internal lithium backup batteries) hold recognized component approvals under UL, VDE, or Chinese CQC standards.

Procurement contracts must explicitly stipulate that Certificates of Analysis must cite the full, dated standard string (e.g., IEC 60601-1:2005+AMD1:2012+AMD2:2020 CSV) accompanied by the accredited laboratory's report number and accreditation scope.

Why YY 9706.102-2021 EMC and YY 9706.111 home-care collaterals are distinct from the general safety CoA

A common point of confusion among procurement officers sourcing Chinese active medical devices is conflating general electrical safety with collateral standards. An active medical device cannot be authorized for clinical deployment based solely on a Part 1 general safety report. In China's regulatory system, collateral standards carry the industry prefix YY 9706, and two specific collateral documents govern active perioperative and outpatient equipment:

1. YY 9706.102-2021 (Electromagnetic Compatibility / EMC): On 1 May 2023, China implemented YY 9706.102-2021, completely replacing the historical EMC standard YY 0505-2012 ⁹. The public SAMR card does not print the IEC 60601-1-2 edition string. Industry 采标 tables commonly record modified adoption of IEC 60601-1-2:2007; that is not independent confirmation of the SAMR catalog, and it is not FDA Rec 19-36. Rec 19-36 names IEC 60601-1-2 Edition 4.1 2020-09 as Partial ⁷. Partial here is a narrow SIS exclusion (Figure 3's 'nursing homes' example and a Note k citation in Subclause 8.9, Table 8)—not a statement that Edition 4.1 wireless-proximity tests are unrecognized. An incoming Chinese EMC report under YY 9706.102-2021 is still not a Rec 19-36 Edition 4.1 file.

2. YY 9706.111-2021 (Home Healthcare Environment): Many active medical devices, including ambulatory NPWT pumps equipped with rechargeable batteries and optional 12 V vehicle DC power adapters, may be indicated for use outside professional healthcare facilities. When the manufacturer's IFU includes home-care use, China enforces YY 9706.111-2021 ¹⁰. The public SAMR card does not print the IEC 60601-1-11 edition string; do not invent that 采标 from the title alone. In the US, the current IEC CSV recognition is FDA Rec 19-38 (IEC 60601-1-11 Edition 2.1 2020-07, Partial—excluding only Note 2 to entry in Sub-clause 3.1) ¹⁶, with US national differences in Rec 19-47 (ANSI/AAMI HA60601-1-11:2015 including AMD1:2021, Complete) ¹⁷. Rec 19-4 is not this collateral.

A general electrical safety CoA citing GB 9706.1-2020 does not prove EMC or home-healthcare collaterals. When auditing an incoming file for an ambulatory device whose IFU includes home use, request three synchronized reports: Part 1 general safety, Part 1-2 EMC, and Part 1-11 home care—each with its named edition.

The NMPA Announcement No. 14 transition clock: What passed on 1 May 2026 for existing registrations

To govern the nationwide transition from the 2007 standard family to the 2020 series, China's NMPA issued Announcement No. 14 of 2023 (dated 28 February 2023, published 16 March 2023) alongside its official regulatory interpretation ³⁴. Announcement No. 14 established clear, legally binding implementation clocks across three distinct regulatory categories:

• New Product Applications (Submitted after 1 May 2023): Any medical device applying for initial Chinese Class II or Class III registration after 1 May 2023 was required to submit full type-test verification reports complying with GB 9706.1-2020 and its applicable collateral standards from day one ³.
• Already-Registered Class II & Class III Devices (Without Particular Standards): For active devices holding valid registration certificates approved before 1 May 2023 where no product-specific Part 2 (专用) standard applied, NMPA granted a three-year change-registration window starting from 1 May 2023 ³¹¹. Manufacturers were required to complete technical modifications, pass type-testing at an NMPA-recognized testing institute, and secure an official Registration Change Approval (医疗器械注册变更文件) on or before 1 May 2026.
• Already-Filed Class I Active Devices: Class I active devices holding domestic filing records prior to May 2023 were granted two years to update filing records to GB 9706.1-2020, a deadline that expired on 1 May 2025 ³.

This establishes the calendar for quality audits on 16 September 2026: the three-year change-registration window for legacy Class II and Class III devices without particular standards closed on 1 May 2026—138 days ago ³. If a quoted Chinese active device still carries a pre-2023 registration number, request the change-registration evidence actually held. Missing paperwork is a China-registration question; it is not automatic proof that every export lot is unsafe, and it is not Rec 19-49.

Importers must understand that NMPA Announcement No. 14 is a domestic Chinese regulatory transition rule. Demonstrating that a Chinese factory completed their GB 9706.1-2020 change registration satisfies Chinese domestic law, but it does not automatically satisfy US FDA Rec 19-49 or EU MDR requirements. It proves only that the domestic regulatory prerequisite has been met.

Active Horizons and Implementation Clocks Across Electrical Safety Standards

To visualize the divergence in standard lifespans and regulatory implementation horizons, the chart below illustrates the active duration of governing electrical safety standards and consensus recognition periods as of 16 September 2026.

Red-flag checklist: Five incoming electrical safety CoA failure modes that require immediate send-back

When quality engineering teams review supplier documentation for active medical devices, specific discrepancies should immediately halt product acceptance. Below are five proven red flags that require returning the Certificate of Analysis to the supplier for corrective documentation:

• Red Flag 1: A CoA Citing GB 9706.1-2007 Issued in 2026: If a batch release certificate dated in 2026 cites GB 9706.1-2007, the manufacturer is documenting release against an abolished standard. The file must be sent back with a formal request for the GB 9706.1-2020 test certificate and the corresponding NMPA Change Registration Approval.
• Red Flag 2: The Bare 'IEC 60601-1' Conformance Claim: A document asserting general compliance with 'IEC 60601-1' without specifying the publication edition (Edition 3.1 vs. Edition 3.2) or amendment status must be rejected. The supplier must provide the full CB Test Certificate showing the exact standard edition and accredited test laboratory accreditation marks.
• Red Flag 3: GB 9706.1-2020 Offered as a Direct Substitute for FDA Rec 19-49: A supplier asserting that their GB 9706.1-2020 report satisfies US 510(k) requirements without providing supplementary testing for Rec 19-46 US national differences and Amendment 2:2020 must be sent back. The buyer must demand the ANSI/AAMI ES60601-1 test report.
• Red Flag 4: YY 9706.102 Offered as FDA Rec 19-36 Edition 4.1 EMC: A domestic Chinese EMC report under YY 9706.102-2021 does not close the Rec 19-36 cell. Rec 19-36 names IEC 60601-1-2 Edition 4.1 as Partial for two SIS exclusions; Partial is not a licence to treat the China EMC collateral as Edition 4.1.
• Red Flag 5: Missing Home-Healthcare Collateral (YY 9706.111 / IEC 60601-1-11) for Ambulatory Devices: If an active device is powered by internal batteries or indicated for home or transport use, but the supplier provides only a Part 1 general safety report, the file is incomplete. Request YY 9706.111-2021 for China and Rec 19-38 plus Rec 19-47 if the US is in scope.

Worked files: Three incoming-audit hypotheses for Chinese active-device CoAs

To show how the identity test works on 16 September 2026, the three files below are hypothesis incoming packs. They use public NMPA registration numbers as clocks (2018 existing Class II versus 2025 first registration). Public product pages do not print the GB or IEC edition on the CoA, so these are not claimed certificates for VEMERIX SKUs.

Worked File A: 2018 NMPA Class II NPWT pump CoA offered into a US 510(k)

Scenario: A US distributor is quoting a microcomputer-controlled NPWT pump that holds an NMPA Class II registration originally approved in 2018 (public example: Lu Mech Reg. 20182140303) ¹². The incoming pack, in this hypothesis, still cites GB 9706.1-2007 and treats the 2018 registration's remaining validity as if it closed electrical-safety identity.

Audit Finding: Send the 2007 header back. SAMR abolished GB 9706.1-2007 on 1 May 2023 ². For a no-particular-standard Class II device, NMPA Announcement No. 14 required change registration to GB 9706.1-2020 within three years of 1 May 2023, that is by 1 May 2026 ³. Request: (1) the NMPA change-registration evidence actually held for that registration, without assuming the named SKU missed or completed it; and (2) if the US is in scope, an accredited report naming IEC 60601-1 Edition 3.2 plus Rec 19-46 rather than treating the GB as Rec 19-49 ⁵⁶. If the IFU includes home or vehicle-DC use, also request the home-healthcare collateral against Rec 19-38 / Rec 19-47, not Rec 19-4 ¹⁶¹⁷.

Worked File B: 2025 first-registration pneumatic injector CoA offered as Rec 19-49

Scenario: An aesthetic-device distributor evaluates a pneumatic-controlled microinjection system holding a 2025 initial NMPA Class II registration (public example: Lu Mech Reg. 20252140023) ¹³. In this hypothesis, the factory delivers a GB 9706.1-2020 and YY 9706.102-2021 type-test summary and offers it as if it were Rec 19-49.

Audit Finding: A 2025 first registration sits after 1 May 2023, so NMPA No. 14 required new-standard reports for that China application ¹³. That China clock is not Rec 19-49. SAMR records GB 9706.1-2020 as modified adoption of IEC 60601-1:2012 (Edition 3.1), whereas Rec 19-49 names Edition 3.2 plus Rec 19-46 US differences ⁵⁶. Public product pages do not print the test-report edition for this SKU; request the named string rather than assume the 2020 GB already includes Amendment 2:2020.

Worked File C: Bare IEC 60601-1 string offered for EU MDR technical documentation

Scenario: An EU importer preparing a technical file under Regulation (EU) 2017/745 (MDR) for an active surgical suction unit receives a supplier declaration of conformity stating compliance with 'IEC 60601-1 and EN 60601-1' without edition references.

Audit Finding: Send the undated string back. The 17 June 2026 consolidated MDR harmonised-standards list (Commission Implementing Decision (EU) 2021/1182) names EN 60601-1:2006 and EN 60601-1:2006/A13:2024 at Item 65 ⁸. A13 is a European amendment, not IEC Amendment 2:2020. Request a Declaration of Conformity that prints that dated EN string before treating the identity cell as closed.

Negative Example: Partner-supplied NOVACURE laser generator and IEC 60601-2-22

Keep general electrical safety distinct from particular standards for energy-delivery consoles. VEMERIX's NMPA-registered single-use medical laser fiber is not the diode laser console. The partner-supplied NOVACURE source is a different legal manufacturer: Guangdong Yunshang, Guo Xie Zhu Zhun 20253011190 ¹⁸.

The generator electrical-safety dossier is a particular (专用) file: IEC 60601-2-22 and China's GB 9706.222-2022 (mandatory, implemented 1 May 2024) ¹⁹. A sterile, passive consumable—such as a single-use laser fiber, puncture kit, or NPWT dressing kit—does not carry that CoA. Do not confuse dressing-kit interchangeability with pump electrical-safety identity, and do not treat IEC 60601-2-22 as the NPWT pump particular.

Where VEMERIX fits—and where due diligence still begins

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care. Public product pages record two NMPA Class II active devices in this article's scope: the Medical Vacuum NPWT Pump (Lu Mech Reg. 20182140303) and the Magic Injector Series (Lu Mech Reg. 20252140023) ¹²¹³. Those pages do not name a GB 9706.1 edition, Rec 19-49 certificate, or EN 60601-1:2006/A13:2024 Declaration of Conformity.

Because both systems are microcomputer-controlled medical electrical equipment, China's mandatory GB 9706 architecture governs domestic type-testing. An NMPA Class II registration is the first positive signal in the buyer's checklist; it is not Rec 19-49. Due diligence still begins with the named standard string on the CoA the buyer holds:

• Named string, not an assumed certificate: VEMERIX can discuss the GB actually printed on the CoA a buyer holds. This article does not invent a completed GB 9706.1-2020 change-registration close-out or a Rec 19-49 file.
• Destination overlay: For US or EU private-label and OEM discussions, due diligence still begins by matching that string to Rec 19-49 plus Rec 19-46, or to EN 60601-1:2006/A13:2024—not by treating GB 9706.1-2020 as interchangeable.
• Collateral files: EMC (YY 9706.102-2021 versus Rec 19-36) and home-healthcare (YY 9706.111-2021 versus Rec 19-38 / Rec 19-47) are separate reports when the IFU claims those environments.

We invite prospective international distributors, hospital procurement engineers, and OEM partners to initiate technical review by contacting our international engineering desk at vemerix.com/contact or inspecting our quality systems framework at vemerix.com/quality.

Distributor and hospital procurement RFQ checklist: Electrical-safety incoming audit gates

To protect medical device importers from accepting non-compliant active equipment, procurement requests for quotation (RFQs) and incoming inspection standard operating procedures should enforce the following structured verification checklist:

• Gate 1: Verify the Exact Standard Identifier and Year: The CoA must print the complete standard code and year. For China lot release after 1 May 2023, GB 9706.1-2020 is the in-force GB; GB 9706.1-2007 is abolished. For a US 510(k) DoC path, ask for IEC 60601-1 Edition 3.2 plus Rec 19-46 rather than a bare 60601 string.
• Gate 2: Audit NMPA Change Registration Evidence: For Chinese Class II/III devices registered before May 2023 with no particular standard, request the NMPA change-registration evidence for GB 9706.1-2020. The 1 May 2026 clock is a China-registration overlay, not Rec 19-49.
• Gate 3: Verify Destination-Market Overlay Requirements: If the US is in scope, request an accredited report naming Rec 19-49 (Edition 3.2) and Rec 19-46 (ANSI/AAMI ES60601-1 including AMD2:2021). If the EU is in scope, verify that the declaration cites EN 60601-1:2006/A13:2024.
• Gate 4: Review Electromagnetic Compatibility (EMC) Files: Inspect the standalone EMC report. YY 9706.102-2021 is the China collateral; Rec 19-36 is IEC 60601-1-2 Edition 4.1 Partial. Do not treat them as identical.
• Gate 5: Audit Home-Healthcare Environment Testing: If the IFU includes home, outpatient, or vehicle-DC use, request YY 9706.111-2021 for China and Rec 19-38 plus Rec 19-47 for the US. Rec 19-4 is not this collateral.
• Gate 6: Inspect the Accredited Report, Not a Bare CoA Line: Prefer the type-test report number, laboratory accreditation scope, and—if supplied—the CB report's critical-component table. A CoA that only recites 'IEC 60601-1' is not enough.

Frequently asked questions

Is GB 9706.1-2020 identical to IEC 60601-1 Edition 3.2?
No. SAMR records GB 9706.1-2020 as a modified adoption (修改采用 / MOD) of IEC 60601-1:2012 (Edition 3.1). The public catalog does not show IEC Amendment 2:2020, which is what makes Edition 3.2. Modified adoption also means Chinese national differences exist; this page does not reprint the paywalled difference table.

Can a US 510(k) accept a GB 9706.1-2020 type-test report in place of Rec 19-49?
Not as a drop-in. Rec 19-49 names IEC 60601-1 Edition 3.2 2020-08 CONSOLIDATED VERSION as Complete, with US national differences applied through Rec 19-46. A GB 9706.1-2020 report can be supporting engineering data. It does not, by itself, close the Rec 19-49 cell.

What happened on 1 May 2026 for Chinese Class II medical electrical equipment already registered before 2023?
Under NMPA Announcement No. 14 of 2023, already-registered Class II and Class III medical electrical equipment without a particular standard had three years from 1 May 2023 to finish change registration to GB 9706.1-2020. That window closed on 1 May 2026. Missing change-registration evidence is a China-registration question to send back; it is not automatic proof that every export lot is unsafe, and it is not Rec 19-49.

If a CoA still cites GB 9706.1-2007 in September 2026, is the device illegal to export?
Export legality depends on the destination market's customs, registration, and procurement terms. A 2007 GB CoA does not prove the hardware is unsafe, but it does prove the quality-release string is citing an abolished China GB. Treat that identity cell as open until the factory names the in-force GB and, if the US or EU is in scope, the destination overlay.

Does YY 9706.102-2021 prove IEC 60601-1-2 Edition 4.1 electromagnetic compatibility?
Not automatically. YY 9706.102-2021 is China's mandatory EMC collateral, implemented 1 May 2023, replacing YY 0505-2012. The public SAMR card does not print the IEC edition. Rec 19-36 names IEC 60601-1-2 Edition 4.1 as Partial for two SIS exclusions; that Partial flag is not a statement that the China EMC report already is Edition 4.1.

Is EN 60601-1:2006/A13:2024 the same as IEC Amendment 2:2020?
No. Amendment A13:2024 to EN 60601-1:2006 is a European regional amendment authored by CENELEC and published in the European Commission's 17 June 2026 consolidated list of MDR harmonised standards (Decision 2021/1182). It aligns European technical requirements directly with the General Safety and Performance Requirements of MDR 2017/745. IEC Amendment 2:2020 is an international technical amendment published by the IEC.

Does an NPWT dressing-kit 510(k) or OMP product code prove the pump's electrical-safety edition?
No. Sterile consumables—such as wound dressings, drainage tubing, and canisters—are passive devices evaluated under biocompatibility (ISO 10993) and sterilization (ISO 11135) standards. The electrical safety of an active vacuum pump (FDA product code OMP) requires independent electrical safety and EMC evaluation. Dressing-kit clearances cannot substitute for pump electrical safety files.

Does VEMERIX claim a completed GB 9706.1-2020 change registration or a Rec 19-49 certificate in this article?
No. This article provides neutral regulatory and procurement guidance for international buyers auditing incoming electrical safety documentation. While VEMERIX manufactures NMPA-registered active equipment (including the Medical Vacuum NPWT Pump and Magic Injector Series), we do not publish proprietary test reports or claim universal Rec 19-49 certificates in editorial articles. Prospective partners are encouraged to request specific commercial configuration files during technical qualification.